The treatment of migraine with propranolol

Neurology

Volumn 22, Issue 4, 1972, Pages 366-369

  Weber, Ronald B ^a   Reinmuth, Oscar M ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; PROPRANOLOL;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MIGRAINE; SEX DIFFERENCE;

ADULT; CLINICAL TRIALS; EVALUATION STUDIES; FEMALE; HUMAN; MALE; MIDDLE AGE; MIGRAINE; PLACEBOS; PROPRANOLOL; SEX FACTORS;

EID: 0015323239     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/wnl.22.4.366     Document Type: Article

References (27)

1. Rabkin R, Stables DP, Levin NW, et al: Propranolol and prophylaxis of angina pectoris. Amer J Cardiol 18:370, 1966.
2. Wykes P: The treatment of angina pectoris with coexisting migraine. Practitioner 200:702, 1968.
3. Bekes M, Matos L, Rausch J, et al: Treatment of migraine with propranolol. Lancet 2:980, 1968.
4. Fujishima M, Reinmuth OM: Unpublished observations.
5. Classification of headache. JAMA 179:717, 1962.
6. Steven SA: Unwanted effects of propranolol. Amer J Cardiol 18:463, 1966.
7. Ahlquist HP: Study of the adrenotropic receptors. Amer J Physiol 153:586, 1948.
8. Furchgott RF: The pharmacological differentiation of adrenergic receptors. Ann NY Acad Sci 139:553, 1967.
9. Sutherland EW, Rail TW: The relation of adenosine-3′,5′-phosphate and phosphorylase to the actions of catecholamines and other hormones. Pharmacol Rev 12:265, 1960.
10. Ali HI, Antonio A, Haugaard N: The action of sympathomimetic amines and adrenergic blocking agents on tissue phosphorylase activity. J Pharmacol Exp Ther 145:142, 1964.
11. Haugaard N, Hess ME: Actions of autonomic drugs on phosphorylase activity and function. Pharmacol Rev 17:27, 1965.
12. Mayer SE, Williams BJ, Smith JM: Adrenergic mechanisms in cardiac glycogen metabolism. Ann NY Acad Sci 139:686, 1967.
13. Nelson E, Rennels M: Innervation of intracranial arteries. Brain 93:475, 1970.
14. Shanks RG: The pharmacology of beta sympathetic blockade. Amer J Cardiol 18:308, 1966.
15. Sowton E, Hamer J: Hemodynamic changes after beta-adrenergic blockade. Amer J Cardiol 18:317, 1966.
16. Brick I, Glover WE, Hutchison KJ, et al: Effects of propranolol on peripheral vessels in man. Amer J Cardiol 18:329, 1966.
17. Charbon GA, Reneman RS: The effects of beta-receptor agonists and antagonists on regional blood flow. Europ J Pharmacol 9:21, 1970.
18. Wolff HG, Tunis MM: Analysis of cranial artery pressure pulse waves in patients with vascular headache of the migraine type. Trans Ass Amer Physicians 65:240, 1952.
19. Wolff HG: Headache and Other Head Pain. New York, Oxford University Press, 1963.
20. Estler CJ, Ammon HPT: The influence of the beta-sympathicolytic agent propranolol on glycogenolysis and glyolysis in muscle, brain and liver of white mice. Biochem Pharmacol 15:2031, 1966.
21. Estler CJ, Ammon HPT: Antagonistic effects of dopa and propranolol on brain glycogen. J Pharm Pharmacol 22:146, 1970.
22. Laubie M, Drouillat M: Action de I’isoprotérénol sur l'hémodynamique et le métabolisme cérébral du chien. Arch Int Pharmaeodyn 170:93, 1967.
23. Rosenblum WZ: Cerebral arteriolar spasm inhibited by beta-adrenergic blocking agents. Arch Neurol (Chicago) 21:296, 1969.
24. Usubiaga JE: Neuromuscular effects of beta-adrenergic blockers and their interaction with skeletal muscle relaxants. Anesthesiology 29:484, 1968.
25. Vaughn Williams EM: Central nervous system effects of beta-adrenergic blocking drugs. Ann NY Acad Sci 139:808, 1967.
26. Leszkovszky G, Tardos L: Some effects of propranolol on the central nervous system. J Pharm Pharmacol 17:518, 1965.
27. Whitsitt LS, Lucchesi BR: Effects of propranolol and its stereoisomers upon coronary vascular resistance. Circ Res 21:305, 1967.